SURI vs. CNCR ETF Comparison
Comparison of Simplify Exchange Traded Funds Simplify Propel Opportunities ETF (SURI) to Loncar Cancer Immunotherapy ETF (CNCR)
SURI
Simplify Exchange Traded Funds Simplify Propel Opportunities ETF
SURI Description
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$22.82
Average Daily Volume
19,901
10
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$15.86
Average Daily Volume
44,815
71
Performance
| Period | SURI | CNCR |
|---|---|---|
| 30 Days | -6.64% | -0.06% |
| 60 Days | -11.27% | -8.85% |
| 90 Days | 11.68% | 8.50% |
| 12 Months | 16.82% | 19.27% |
0 Overlapping Holdings
| Symbol | Grade | Weight in SURI | Weight in CNCR | Overlap |
|---|
SURI Underweight 71 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| GERN | B | -2.87% | |
| ACRV | B | -2.63% | |
| ELVN | B | -2.13% | |
| JANX | A | -1.79% | |
| NUVB | B | -1.7% | |
| CGEM | A | -1.57% | |
| RVMD | A | -1.56% | |
| HCM | B | -1.54% | |
| TSVT | D | -1.51% | |
| DAWN | A | -1.5% | |
| BPMC | A | -1.48% | |
| MRK | B | -1.48% | |
| EXEL | D | -1.47% | |
| LYEL | C | -1.46% | |
| YMAB | C | -1.43% | |
| MOR | C | -1.41% | |
| BCYC | C | -1.39% | |
| PGEN | D | -1.39% | |
| INBX | D | -1.38% | |
| ITOS | C | -1.38% | |
| IMCR | D | -1.37% | |
| MGNX | D | -1.37% | |
| NRIX | D | -1.37% | |
| IPHA | D | -1.36% | |
| AURA | D | -1.34% | |
| BNTX | D | -1.33% | |
| REGN | B | -1.33% | |
| RAPT | F | -1.32% | |
| GMAB | D | -1.32% | |
| MRUS | C | -1.32% | |
| VOR | F | -1.32% | |
| BMY | F | -1.31% | |
| SDGR | F | -1.31% | |
| SNDX | D | -1.29% | |
| DCPH | A | -1.29% | |
| ACET | F | -1.28% | |
| TYRA | C | -1.27% | |
| ERAS | D | -1.27% | |
| GLUE | D | -1.26% | |
| IDYA | D | -1.25% | |
| KYMR | D | -1.25% | |
| SWTX | D | -1.23% | |
| PRLD | D | -1.22% | |
| FHTX | D | -1.21% | |
| XNCR | C | -1.21% | |
| STRO | F | -1.21% | |
| KURA | D | -1.2% | |
| IMTX | D | -1.19% | |
| RCUS | F | -1.18% | |
| ZNTL | F | -1.17% | |
| IOVA | D | -1.16% | |
| KPTI | F | -1.14% | |
| NUVL | D | -1.12% | |
| DNA | F | -1.12% | |
| IGMS | C | -1.1% | |
| RLAY | F | -1.09% | |
| ACLX | D | -1.07% | |
| SMMT | C | -1.06% | |
| AUTL | F | -1.04% | |
| RXRX | F | -1.03% | |
| ARVN | D | -1.02% | |
| REPL | F | -1.01% | |
| CRBU | F | -1.01% | |
| LEGN | F | -0.96% | |
| ALLO | F | -0.95% | |
| BMEA | F | -0.9% | |
| RPTX | F | -0.89% | |
| FATE | D | -0.83% | |
| MRSN | D | -0.81% | |
| GNLX | F | -0.78% | |
| IMRX | F | -0.73% |
SURI: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
